<DOC>
	<DOC>NCT03036748</DOC>
	<brief_summary>The aim of this study is to determine if amiloride, a diuretic drug, is capable of increasing renal salt excretion, lowering blood pressure and inhibiting uPA in kidney transplant recipients with proteinuria compared to normoalbuminuric transplant patients.</brief_summary>
	<brief_title>Increased Activity of ENaC in Proteinuric Kidney Transplant Recipients</brief_title>
	<detailed_description />
	<mesh_term>Amiloride</mesh_term>
	<criteria>One Group of kidney transplant recipients with ACR&lt; 30mg/g One Group of kidney transplant recipients with ACR &gt;300mg/g Negative pregnancy test at inclusion and taking contraceptive medication Receiving amiloride, glucocorticoids, aldosterone or spironolactone Clinically relevant organic or systemic disease including malignancy eGFR or creatininclearance &lt; 30ml/min hyperkalemia (spotassium &gt; 5,0mmol/l)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>